Clinical Trials Directory

Trials / Completed

CompletedNCT00612378

A Multi-center Acute Efficacy Trial of GFX For Reduction of Glabellar Furrowing

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
94 (actual)
Sponsor
Advanced Cosmetic Intervention · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this research study is to evaluate the immediate effectiveness of the GFX™ device in reducing the furrows (deep frown lines) between eyebrows (glabellar region).

Detailed description

The purpose of this research study is to evaluate the acute ability of GFX to reduce glabellar furrowing. Patients who have presented to the investigator for correction of glabellar furrows, as classified per the Rated Numeric Kinetic Line Scale Score for Facial Wrinkles Secondary to Hyperkinetic Function (Note: Class 1 or Higher)7 (Appendix N) are candidates for this study. All patients must consent to the procedure and agree to complete their post treatment evaluation visit.

Conditions

Interventions

TypeNameDescription
DEVICEGFX SystemThe GFX system employs minimally invasive technique utilizing bi-polar radio frequency (RF) technology. GFX ablates nerves activating the muscles that cause glabellar furrowing.

Timeline

Start date
2007-09-01
Primary completion
2008-02-01
Completion
2008-03-01
First posted
2008-02-11
Last updated
2014-06-24

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00612378. Inclusion in this directory is not an endorsement.